Positive effect of baclofen on body weight reduction in obese subjects: A pilot study

Internal Medicine

Volumn 49, Issue 19, 2010, Pages 2043-2047

  Arima, Hiroshi ^a   Oiso, Yutaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Baclofen; Leptin; Obesity

Indexed keywords

AMLODIPINE BESYLATE; ATORVASTATIN; BACLOFEN; CANDESARTAN HEXETIL; FUROSEMIDE; GLUCOSE; IMIDAPRIL; LEPTIN; LIPID; LOSARTAN POTASSIUM; METFORMIN; PIOGLITAZONE; VOGLIBOSE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; DIABETES MELLITUS; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DYSLIPIDEMIA; FEMALE; GLUCOSE METABOLISM; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID METABOLISM; MALE; OBESITY; PILOT STUDY; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADIPONECTIN; ADULT; ANIMALS; ANTI-OBESITY AGENTS; APPETITE; BACLOFEN; BLOOD GLUCOSE; BLOOD PRESSURE; FEMALE; GABA-B RECEPTOR AGONISTS; HUMANS; LEPTIN; LIPIDS; MALE; MICE; MIDDLE AGED; OBESITY; PILOT PROJECTS; WEIGHT LOSS;

EID: 77958096750     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3918     Document Type: Article

References (17)

1. Whitlock G, Lewington S, Sherliker P, et al; Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies. Lancet 373: 1083-1096, 2009.
2. James PT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 11: 3-8, 2004.
3. Li M, Cheung BMY. Pharmacotherapy for obesity. Br J Clin Pharmacol 68: 804-810, 2009.
4. Rawlins PK. Intrathecal baclofen therapy over 10 years. J Neurosci Nurs 36: 322-327, 2004.
5. Sato I, Arima H, Ozaki N, et al. Insulin inhibits neuropeptide Y gene expression in the arcuate nucleus through GABAergic systems. J Neurosci 25: 8657-8664, 2005.
6. Sato I, Arima H, Ozaki N, et al. Peripherally administered baclofen reduced food intake and body weight in db/db as well as diet-induced obese mice. FEBS Letters 581: 4857-4864, 2007.
7. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
8. Flier JS. Leptin expression and action: new experimental paradigms. Proc Natl Acad Sci USA 94: 4242-4245, 1997.
9. Defronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 339: 541-549, 2005.
10. van Bree JB, Heijligers-Feijen CD, de Boer AG, Danhof M, Breimer DD. Stereoselective transport of baclofen across the bloodbrain barrier in rats as determined by the unit impulse response methodology. Pharm Res 8: 259-262, 1991.
11. Clark JT, Kalra PS, Crowley WR, Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115: 427-429, 1984.
12. Cousins MS, Roberts DC, Wit H. GABAB receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend 65: 209-220, 2002.
13. Addolorat G, Leggio L, Ferrulli A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcoholdependent patients with liver cirrhosis: randomized, doubleblinded controlled study. Lancet 370: 1915-1922, 2007.
14. Buda-Levin A, Wojnicki FH, Corwin RL. Baclofen reduces fat intake under binge-type conditions. Physiol Behav 86: 176-184, 2005.
15. Broft AI, Spanos A, Corwin RL, et al. Baclofen for binge eating: an open-label trial. Int J Eat Disord 40: 687-691, 2007.
16. Rapaka R, Schnur P, Shurtleff D. Obesity and addiction: Common neurological mechanisms and drug development. Physiol Behav 95: 2-9, 2008.
17. Carlezon WA Jr, Thomas MJ. Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 56 Supple 1: 122-132, 2009.